Company profile: Cartiva
1.1 - Company Overview
Company description
- Provider of innovative therapies and synthetic cartilage implants for treating osteoarthritis and cartilage injuries. Products include the Cartiva Synthetic Cartilage Implant, designed to repair osteochondral defects with properties similar to cartilage, used in the first metatarsophalangeal joint.
Products and services
- Cartiva Synthetic Cartilage Implant: Biomimetic, implant-grade device engineered to repair osteochondral defects with properties similar to cartilage, used for treating osteoarthritis in the first metatarsophalangeal joint
- Development and Marketing of Novel Therapies: Research-driven service offers products helping physicians treat osteoarthritis or cartilage damage, improving quality of life
- Venture-backed, spun out from Carticept Medical in 2011
- Synthetic Cartilage Implant: Orthopedic-grade implant engineered as a cartilage-like component to repair osteochondral defects, particularly for treating osteoarthritis in the first metatarsophalangeal joint
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cartiva
Pristine Surgical
HQ: United States
Website
- Description: Provider of a first-of-its-kind single-use visualization platform for surgical and diagnostic rigid endoscopic procedures, including Summit, a 4K single-use arthroscope, and Pristine Connect cloud software for operational efficiency, automated inventory management, and digital training. Offers a subscription pricing model with transparent pricing and is developing a full portfolio of rigid and flexible endoscopes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pristine Surgical company profile →
Bioventus
HQ: United States
Website
- Description: Provider of clinically proven, cost-effective products that help people heal quickly and safely.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioventus company profile →
Soteira
HQ: United States
Website
- Description: Provider of next-generation technologies for the treatment of vertebral compression fractures, with multiple products launched to advance patient care in osteoporotic bone repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soteira company profile →
X2 Biosystems
HQ: United States
Website
- Description: Provider of wearable impact sensors, neurocognitive assessment tools, and a cloud-based data platform that enhance concussion detection and management. End-to-end platform for sports, military, and civilian use, including the ICE app for SCAT-based baseline, post-impact, and recovery monitoring, and a tablet system facilitating collaboration among trainers, players, and healthcare providers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full X2 Biosystems company profile →
Millet Innovation
HQ: France
Website
- Description: Provider of medical and cosmetic personal care products, designing, manufacturing and marketing solutions distributed under the Epitact brand. Its Epitact Podologie line offers around 40 podiatry foot care products, including treatments for aches and pains, callus, corns and damaged nails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Millet Innovation company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cartiva
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cartiva
2.2 - Growth funds investing in similar companies to Cartiva
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cartiva
4.2 - Public trading comparable groups for Cartiva
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →